Ovation Science Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Terry Howlett

İcra Kurulu Başkanı

CA$124.8k

Toplam tazminat

CEO maaş yüzdesi	92.0%
CEO görev süresi	7.1yrs
CEO sahipliği	10.8%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	6.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Terry Howlett'un ücretlendirmesi Ovation Science'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-CA$637k
Mar 31 2024	n/a	n/a	-CA$823k
Dec 31 2023	CA$125k	CA$115k	-CA$813k
Sep 30 2023	n/a	n/a	-CA$794k
Jun 30 2023	n/a	n/a	-CA$800k
Mar 31 2023	n/a	n/a	-CA$752k
Dec 31 2022	CA$157k	CA$157k	-CA$794k
Sep 30 2022	n/a	n/a	-CA$2m
Jun 30 2022	n/a	n/a	-CA$2m
Mar 31 2022	n/a	n/a	-CA$2m
Dec 31 2021	CA$163k	CA$163k	-CA$2m
Sep 30 2021	n/a	n/a	-CA$801k
Jun 30 2021	n/a	n/a	-CA$848k
Mar 31 2021	n/a	n/a	-CA$1m
Dec 31 2020	CA$202k	CA$163k	-CA$1m
Sep 30 2020	n/a	n/a	-CA$1m
Jun 30 2020	n/a	n/a	-CA$1m
Mar 31 2020	n/a	n/a	-CA$759k
Dec 31 2019	CA$155k	CA$152k	-CA$836k
Sep 30 2019	n/a	n/a	-CA$739k
Jun 30 2019	n/a	n/a	-CA$678k
Mar 31 2019	n/a	n/a	-CA$615k
Dec 31 2018	CA$75k	CA$72k	-CA$508k
Dec 31 2017	CA$74k	CA$18k	-CA$148k

Tazminat ve Piyasa: Terry 'nin toplam tazminatı ($USD 89.14K ), Canadian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 169.13K ).

Tazminat ve Kazançlar: Terry 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Terry Howlett (76 yo)

7.1yrs

Görev süresi

CA$124,750

Tazminat

Mr. Terry H. Howlett has been the Chief Executive Officer and President of Skinvisible Inc. since March 5, 1998 and serves as its Chief Financial Officer and Principal Accounting Officer also served as its...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Terry Howlett	President	7.1yrs	CA$124.75k	10.83% CA$ 114.6k
Doreen McMorran	CFO, VP	7.1yrs	CA$101.80k	10.96% CA$ 115.9k
Joan Chypyha	Independent Director	6.8yrs	CA$12.00k	0.85% CA$ 9.0k
Shane Dungey	Independent Director	1.1yrs	CA$35.00k	Veri yok
Ian Howard	Independent Director	6.8yrs	CA$12.00k	0.43% CA$ 4.5k
Ronald Stern	Independent Director	1.1yrs	CA$35.00k	Veri yok

6.8yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: OVAT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).

Ovation Science Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

Ovation Science Inc., Annual General Meeting, Sep 20, 2024

Insufficient new directors

Insufficient new directors

Insufficient new directors

Ovation Science Inc., Annual General Meeting, Aug 22, 2023

Recent updates

New major risk - Financial position

Second quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.009 loss in 2Q 2023)

Less than half of directors are independent

Ovation Science Inc., Annual General Meeting, Sep 20, 2024

Full year 2023 earnings released: CA$0.027 loss per share (vs CA$0.027 loss in FY 2022)

Ovation Science Inc. announced that it has received $0.05 million in funding

Ovation Science Inc. announced that it expects to receive CAD 0.0675 million in funding

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 3Q 2022)

New minor risk - Shareholder dilution

Ovation Science Inc. announced that it has received CAD 0.2 million in funding

Ovation Science Inc. announced that it expects to receive CAD 0.2 million in funding

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.007 loss in 2Q 2022)

Insufficient new directors

Insufficient new directors

Insufficient new directors

Ovation Science Inc., Annual General Meeting, Aug 22, 2023

First quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.007 loss in 1Q 2022)

Insufficient new directors

Full year 2022 earnings released: CA$0.027 loss per share (vs CA$0.081 loss in FY 2021)

Insufficient new directors

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 3Q 2021)

Insufficient new directors

Insufficient new directors

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2021)

Ovation Science Inc., Annual General Meeting, Oct 27, 2022

Insufficient new directors

First quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.006 loss in 1Q 2021)

Insufficient new directors

Full year 2021 earnings released: CA$0.081 loss per share (vs CA$0.044 loss in FY 2020)

Insufficient new directors

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: CA$0.007 loss per share (vs CA$0.025 loss in 2Q 2020)

First quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1Q 2020)

Full year 2020 earnings released: CA$0.044 loss per share (vs CA$0.052 loss in FY 2019)

Ovation Science Inc. Enters into a Non-Exclusive Distribution Agreement for its DermSafe® Hand Sanitizer with CDMV

New 90-day low: CA$0.27

New 90-day low: CA$0.29

Third quarter 2020 earnings released: CA$0.01 loss per share

New 90-day low: CA$0.30

New 90-day low: CA$0.35

New 90-day low - CA$0.42

First half earnings released

Ovation Science Inc. (CNSX:OVAT) acquired World Rights to DermSafe® Hand Sanitizer from Skinvisible, Inc. (OTCPK:SKVI).

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş